| Outcome Measures: |
Primary: Pharmacokinetics parameters of SHR3824 in the fed state: Cmax, Based on pre-dose, 0.25-72 hours post-dose sampling times on Day 1 and Day 8 and Day 15|Pharmacokinetics parameters of SP2086 in the fed state: Cmax, Based on pre-dose, 0.25-72 hours post-dose sampling times on Day 1 and Day 8 and Day 15|Pharmacokinetics parameters of Metformin in the fed state: Cmax, Based on pre-dose, 0.25-72 hours post-dose sampling times on Day 1 and Day 8 and Day 15|Pharmacokinetics parameters of SHR3824 in the fed state: AUC0-t, Based on pre-dose, 0.25-72 hours post-dose sampling times on Day 1 and Day 8 and Day 15|Pharmacokinetics parameters of SP2086 in the fed state: AUC0-t, Based on pre-dose, 0.25-72 hours post-dose sampling times on Day 1 and Day 8 and Day 15|Pharmacokinetics parameters of Metformin in the fed state: AUC0-t, Based on pre-dose, 0.25-72 hours post-dose sampling times on Day 1 and Day 8 and Day 15|Pharmacokinetics parameters of SHR3824 in the fed state: AUC0-inf (if applicable), Based on pre-dose, 0.25-72 hours post-dose sampling times on Day 1 and Day 8 and Day 15|Pharmacokinetics parameters of SP2086 in the fed state: AUC0-inf (if applicable), Based on pre-dose, 0.25-72 hours post-dose sampling times on Day 1 and Day 8 and Day 15|Pharmacokinetics parameters of Metformin in the fed state: AUC0-inf (if applicable), Based on pre-dose, 0.25-72 hours post-dose sampling times on Day 1 and Day 8 and Day 15 | Secondary: Pharmacokinetics parameters of SP2086A in the fed state: Cmax, Based on pre-dose, 0.25-72 hours post-dose sampling times on Day 1 and Day 8 and Day 15|Pharmacokinetics parameters of SP2086A in the fed state: AUC0-t, Based on pre-dose, 0.25-72 hours post-dose sampling times on Day 1 and Day 8 and Day 15|Pharmacokinetics parameters of SP2086A in the fed state: AUC0-inf (if applicable), Based on pre-dose, 0.25-72 hours post-dose sampling times on Day 1 and Day 8 and Day 15|Pharmacokinetics parameters of SHR3824 in the fed state: Tmax, Based on pre-dose, 0.25-72 hours post-dose sampling times on Day 1 and Day 8 and Day 15|Pharmacokinetics parameters of SP2086 and SP2086A in the fed state: Tmax, Based on pre-dose, 0.25-72 hours post-dose sampling times on Day 1 and Day 8 and Day 15|Pharmacokinetics parameters of Metformin in the fed state: Tmax, Based on pre-dose, 0.25-72 hours post-dose sampling times on Day 1 and Day 8 and Day 15|Pharmacokinetics parameters of SHR3824 in the fed state: CL/F, Based on pre-dose, 0.25-72 hours post-dose sampling times on Day 1 and Day 8 and Day 15|Pharmacokinetics parameters of SP2086 and SP2086A in the fed state: CL/F, Based on pre-dose, 0.25-72 hours post-dose sampling times on Day 1 and Day 8 and Day 15|Pharmacokinetics parameters of Metformin in the fed state: CL/F, Based on pre-dose, 0.25-72 hours post-dose sampling times on Day 1 and Day 8 and Day 15|Pharmacokinetics parameters of SHR3824 in the fed state: t1/2, Based on pre-dose, 0.25-72 hours post-dose sampling times on Day 1 and Day 8 and Day 15|Pharmacokinetics parameters of SP2086 and SP2086A in the fed state: t1/2, Based on pre-dose, 0.25-72 hours post-dose sampling times on Day 1 and Day 8 and Day 15|Pharmacokinetics parameters of Metformin in the fed state: t1/2, Based on pre-dose, 0.25-72 hours post-dose sampling times on Day 1 and Day 8 and Day 15|The incidence and severity of adverse events/serious adverse events, Based on pre-dose, 0.25-72 hours post-dose sampling times on Day 1 and Day 8 and Day 15
|
